24 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
2 Feb 15
Bio Blast Announces Key Leadership Changes
12:00am
EXHIBIT 99.1
Bio Blast Announces Key Leadership Changes
TEL AVIV, Israel, February 2, 2015 – Bio Blast Pharma Ltd. (NasdaqGM: ORPN), a clinical … leadership changes designed to support the Company’s global clinical efforts, operational scale-up, and pre-commercialization activities. Colin Foster
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
9 Oct 15
Appoints Former Aptalis and Novartis Executive, Theresa M. Stevens, as Chief Corporate Development Officer
12:00am
Exhibit 99.1
BioBlast Pharma Augments Leadership Team
Appoints Former Aptalis and Novartis Executive, Theresa M. Stevens, as Chief Corporate … over 29 years of leadership and operational experience in strategy, corporate and business development, and legal, most recently, as President
6-K
ENLV
Enlivex Therapeutics Ltd
2 Feb 15
Bio Blast Announces Key Leadership Changes
12:00am
on Form 6-K of the registrant consists of the press release issued by the registrant on February 2, 2015, announcing key senior leadership changes
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
23 May 22
Enlivex Appoints Dr. Roger J. Pomerantz to its Board of Directors as Vice Chairman
8:03am
clinical program in solid tumors. With talented leadership, strong data, and expected cash runway into Q3 2024, I believe Enlivex is well positioned
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
1 Mar 21
Report of Foreign Private Issuer
7:58am
, translational research and discovery, and collaborative clinical leadership ensuring that it delivers the highest quality care—from prevention to treatment
6-K
EX-99.1
rv4 uezce
9 Aug 21
Enlivex Announces Second Quarter 2021 Financial Results and Provides a Business Update
8:00am
6-K
EX-99.1
nodqsb
22 Nov 21
Enlivex Announces Third Quarter 2021 Financial Results and Provides a Business Update
8:00am
6-K
EX-99.1
ysxsr
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
6-K
EX-99.1
pixpd
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
6-K
EX-99.1
o7kawunu4c0a5ushr07
30 Sep 21
Annual and Extraordinary General Meeting of Shareholders
8:01am
6-K
4cemc lj4
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.2
56ornu9
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
20-F
impggxo10phn3q
31 Mar 15
Annual report (foreign)
12:00am
F-1/A
vk4mrer7bc4igset
8 Jul 14
Registration statement (foreign) (amended)
12:00am